As you may already know, a large provider of repackaged bevacizumab (Avastin®) recently announced the discontinuation of this service from their portfolio. We understand this may create a significant shortage in the market that could take months to resolve. Given this industry development, many customers have reached out to us with their urgent supply needs.
At Leiters Health, we recognize the critical role repackaged Avastin plays in your efforts to provide an affordable, sight-saving solution to your patients. We are committed to addressing the needs of our healthcare partners and are currently working diligently to expand our repackaging capabilities and increase our inventory levels.
Since 2018, our repackaged Avastin service has aligned with the FDA’s guidance on the repackaging of biologics. Today, Leiters Health is aware of no other supplier in the United States that meets this guidance, that repackages Avastin using our unique process to remove particulates, and that also utilizes an FDA-cleared intravitreal syringe. This commitment to quality and compliance remains at the core of our mission.
In order to ensure additional support through this transition, we encourage you to reach out to us immediately with your product needs, along with your monthly forecast. To speak live to one of our representatives, please call us at 800.292.6772 or email us at info@leiters.com.
To learn more about our repackaged Avastin service, please visit https://leiters.com/avastin/
Leiters Health is a trusted FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services. We are committed to providing healthcare professionals and their patients with high-quality medications. Our team of experts in sterile pharmaceutical manufacturing, repackaging, and pharmacy provides a sophisticated understanding of what it takes to elevate the quality and consistency of supply in outsourcing.
